Login / Signup

Ozanimod: A First-in-Class Sphingosine 1-Phosphate Receptor Modulator for the Treatment of Ulcerative Colitis.

David ChoiAlyssa P StewartShubha Bhat
Published in: The Annals of pharmacotherapy (2021)
Ozanimod is another option in the growing arsenal of UC treatment. Although it offers a novel mechanism of action and is administered orally, there are important safety, dosing, and pharmacokinetic factors to consider prior to initiation and use.
Keyphrases
  • ulcerative colitis
  • combination therapy